{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:22:23Z","timestamp":1778127743452,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010345","name":"B.Braun Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010345","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scherbarth Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00134-020-06132-0","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T07:04:16Z","timestamp":1591686256000},"page":"1683-1695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hypertonic saline for fluid resuscitation in ICU patients post-cardiac surgery (HERACLES): a double-blind randomized controlled clinical trial"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-2770","authenticated-orcid":false,"given":"Carmen A.","family":"Pfortmueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelle","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna S.","family":"Messmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Waskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Zuercher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan M.","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Englberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg C.","family":"Schefold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"6132_CR1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00508-017-1180-4","volume":"129","author":"C Pfortmueller","year":"2017","unstructured":"Pfortmueller C, Funk GC, Potura E, Reiterer C, Luf F, Kabon B, Druml W, Fleischmann E, Lindner G (2017) Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: prospective, randomized, controlled trial. Wien Klin Wochenschr 129:598\u2013604","journal-title":"Wien Klin Wochenschr"},{"key":"6132_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13054-019-2423-8","volume":"23","author":"CA Pfortmueller","year":"2019","unstructured":"Pfortmueller CA, Faeh L, Muller M, Eberle B, Jenni H, Zante B, Prazak J, Englberger L, Takala J, Jakob SM (2019) Fluid management in patients undergoing cardiac surgery: effects of an acetate-versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT). Crit Care (Lond, Engl) 23:159","journal-title":"Crit Care (Lond, Engl)"},{"key":"6132_CR3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1378\/chest.126.5.1563","volume":"126","author":"A Kramer","year":"2004","unstructured":"Kramer A, Zygun D, Hawes H, Easton P, Ferland A (2004) Pulse pressure variation predicts fluid responsiveness following coronary artery bypass surgery. Chest 126:1563\u20131568","journal-title":"Chest"},{"key":"6132_CR4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jcrc.2014.07.032","volume":"29","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Woinarski NC, Lipcsey M, Candal CL, Schneider AG, Glassford NJ, Eastwood GM, Bellomo R (2014) Pulse pressure variation-guided fluid therapy after cardiac surgery: a pilot before-and-after trial. J Crit Care 29:992\u2013996","journal-title":"J Crit Care"},{"key":"6132_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13741-017-0071-6","volume":"6","author":"S Aronson","year":"2017","unstructured":"Aronson S, Nisbet P, Bunke M (2017) Fluid resuscitation practices in cardiac surgery patients in the USA: a survey of health care providers. Perioper Med (Lond, Engl) 6:15","journal-title":"Perioper Med (Lond, Engl)"},{"key":"6132_CR6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PCC.0000000000000715","volume":"17","author":"NS Wilder","year":"2016","unstructured":"Wilder NS, Yu S, Donohue JE, Goldberg CS, Blatt NB (2016) Fluid overload is associated with late poor outcomes in neonates following cardiac surgery. Pediatr Crit Care Med 17:420\u2013427","journal-title":"Pediatr Crit Care Med"},{"key":"6132_CR7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejvs.2007.03.010","volume":"34","author":"GT McArdle","year":"2007","unstructured":"McArdle GT, Price G, Lewis A, Hood JM, McKinley A, Blair PH, Harkin DW (2007) Positive fluid balance is associated with complications after elective open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 34:522\u2013527","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"6132_CR8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s13063-019-3420-6","volume":"20","author":"CA Pfortmueller","year":"2019","unstructured":"Pfortmueller CA, Messmer AS, Hess B, Reineke D, Jakob L, Wenger S, Waskowski J, Zuercher P, Stoehr F, Erdoes G, Luedi MM, Jakob SM, Englberger L, Schefold JC (2019) Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial. Trials 20:357","journal-title":"Trials"},{"key":"6132_CR9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ndt\/gfr272","volume":"27","author":"K Shimizu","year":"2012","unstructured":"Shimizu K, Kurosawa T, Ishikawa R, Sanjo T (2012) Vasopressin secretion by hypertonic saline infusion during hemodialysis: effect of cardiopulmonary recirculation. Nephrol Dial Transplant 27:796\u2013803","journal-title":"Nephrol Dial Transplant"},{"key":"6132_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2334-8-50","volume":"8","author":"ZX Fang","year":"2008","unstructured":"Fang ZX, Li YF, Zhou XQ, Zhang Z, Zhang JS, Xia HM, Xing GP, Shu WP, Shen L, Yin GQ (2008) Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis. BMC Infect Dis 8:50","journal-title":"BMC Infect Dis"},{"key":"6132_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11897-010-0018-4","volume":"7","author":"M Liszkowski","year":"2010","unstructured":"Liszkowski M, Nohria A (2010) Rubbing salt into wounds: hypertonic saline to assist with volume removal in heart failure. Curr Heart Fail Rep 7:134\u2013139","journal-title":"Curr Heart Fail Rep"},{"key":"6132_CR12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1034\/j.1399-6576.2001.045006776.x","volume":"45","author":"K Jarvela","year":"2001","unstructured":"Jarvela K, Koobi T, Kauppinen P, Kaukinen S (2001) Effects of hypertonic 75\u00a0mg\/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiol Scand 45:776\u2013781","journal-title":"Acta Anaesthesiol Scand"},{"key":"6132_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/SLA.0000000000000872","volume":"260","author":"H Lavu","year":"2014","unstructured":"Lavu H, Sell NM, Carter TI, Winter JM, Maguire DP, Gratch DM, Berman RA, Feil MG, Grunwald Z, Leiby BE, Pequignot EC, Rosato EL, Yeo CJ (2014) The HYSLAR trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Ann Surg 260:445\u2013453","journal-title":"Ann Surg"},{"key":"6132_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00005373-198906000-00020","volume":"29","author":"JS Cross","year":"1989","unstructured":"Cross JS, Gruber DP, Burchard KW, Singh AK, Moran JM, Gann DS (1989) Hypertonic saline fluid therapy following surgery: a prospective study. J Trauma 29:817\u2013825","journal-title":"J Trauma"},{"key":"6132_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/jcan.2002.29671","volume":"16","author":"K Jarvela","year":"2002","unstructured":"Jarvela K, Kaukinen S (2002) Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. J Cardiothorac Vasc Anesth 16:43\u201346","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"6132_CR16","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/cc11368","volume":"16","author":"A Stein","year":"2012","unstructured":"Stein A, de Souza LV, Belettini CR, Menegazzo WR, Vi\u00e9gas JR, Costa Pereira EM, Eick R, Ara\u00fajo L, Consolim-Colombo F, Irigoyen MC (2012) Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort study. Crit Care (Lond, Engl) 16:R99","journal-title":"Crit Care (Lond, Engl)"},{"key":"6132_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12882-016-0323-6","volume":"17","author":"R Claure-Del Granado","year":"2016","unstructured":"Claure-Del Granado R, Mehta RL (2016) Fluid overload in the ICU: evaluation and management. BMC Nephrol 17:109","journal-title":"BMC Nephrol"},{"key":"6132_CR18","doi-asserted-by":"crossref","first-page":"e0172137","DOI":"10.1371\/journal.pone.0172137","volume":"12","author":"IY Kim","year":"2017","unstructured":"Kim IY, Kim JH, Lee DW, Lee SB, Rhee H, Seong EY, Kwak IS, Song SH (2017) Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy. PLoS ONE 12:e0172137","journal-title":"PLoS ONE"},{"key":"6132_CR19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00134-008-1084-x","volume":"34","author":"J Takala","year":"2008","unstructured":"Takala J, Dellinger RP, Koskinen K, St Andre A, Read M, Levy M, Jakob SM, Mello PV, Friolet R, Ruokonen E (2008) Development and simultaneous application of multiple care protocols in critical care: a multicenter feasibility study. Intensive Care Med 34:1401\u20131410","journal-title":"Intensive Care Med"},{"key":"6132_CR20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1740774515588097","volume":"12","author":"LN Yelland","year":"2015","unstructured":"Yelland LN, Sullivan TR, Voysey M, Lee KJ, Cook JA, Forbes AB (2015) Applying the intention-to-treat principle in practice: guidance on handling randomisation errors. Clin Trials (Lond, Engl) 12:418\u2013423","journal-title":"Clin Trials (Lond, Engl)"},{"key":"6132_CR21","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1353-0","volume-title":"Regression methods in biostatistics","author":"EGD Vittinghoff","year":"2012","unstructured":"Vittinghoff EGD (2012) Regression methods in biostatistics. Springer, Berlin"},{"key":"6132_CR22","doi-asserted-by":"publisher","unstructured":"Shrum B, Church B, McArthur E, Burns KE, Znajda T, McAlister V (2016) Hypertonic salt solution for peri-operative fluid management. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005576.pub3","DOI":"10.1002\/14651858.CD005576.pub3"},{"key":"6132_CR23","first-page":"139","volume":"35","author":"D Croft","year":"1992","unstructured":"Croft D, Dion YM, Dumont M, Langlois D (1992) Cardiac compliance and effects of hypertonic saline. Can J Surg 35:139\u2013144","journal-title":"Can J Surg"},{"key":"6132_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcrc.2019.03.009","volume":"52","author":"L Smart","year":"2019","unstructured":"Smart L, Macdonald SPJ, Bosio E, Fatovich D, Neil C, Arendts G (2019) Bolus therapy with 3% hypertonic saline or 0.9% saline in emergency department patients with suspected sepsis: a pilot randomised controlled trial. J Crit Care 52:33\u201339. https:\/\/doi.org\/10.1016\/j.jcrc.2019.03.009","journal-title":"J Crit Care"},{"key":"6132_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5603\/AIT.2018.0019","volume":"50","author":"K Jarvela","year":"2018","unstructured":"Jarvela K, Rantanen M, Koobi T, Huhtala H, Sisto T (2018) Hypertonic saline-hydroxyethyl starch solution attenuates fluid accumulation in cardiac surgery patients: a randomized controlled double-blind trial. Anaesthesiol Intensive Ther 50:122\u2013127","journal-title":"Anaesthesiol Intensive Ther"},{"key":"6132_CR26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1213\/ANE.0000000000003955","volume":"128","author":"D Orbegozo","year":"2019","unstructured":"Orbegozo D, Vincent JL, Creteur J, Su F (2019) Hypertonic saline in human sepsis: a systematic review of randomized controlled trials. Anesth Analg 128:1175\u20131184","journal-title":"Anesth Analg"},{"key":"6132_CR27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(17)30046-2","volume":"5","author":"P Asfar","year":"2017","unstructured":"Asfar P, Schortgen F, Boisrame-Helms J, Charpentier J, Guerot E, Megarbane B, Grimaldi D, Grelon F, Anguel N, Lasocki S, Henry-Lagarrigue M, Gonzalez F, Legay F, Guitton C, Schenck M, Doise JM, Devaquet J, Van Der Linden T, Chatellier D, Rigaud JP, Dellamonica J, Tamion F, Meziani F, Mercat A, Dreyfuss D, Seegers V, Radermacher P (2017) Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med 5:180\u2013190","journal-title":"Lancet Respir Med"},{"key":"6132_CR28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2369-14-202","volume":"14","author":"JM Jensen","year":"2013","unstructured":"Jensen JM, Mose FH, Bech JN, Nielsen S, Pedersen EB (2013) Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney. BMC Nephrol 14:202","journal-title":"BMC Nephrol"},{"key":"6132_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcrc.2017.06.019","volume":"42","author":"CA Pfortmueller","year":"2017","unstructured":"Pfortmueller CA, Schefold JC (2017) Hypertonic saline in critical illness\u2014a systematic review. J Crit Care 42:168\u2013177","journal-title":"J Crit Care"},{"key":"6132_CR30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cardfail.2010.11.003","volume":"17","author":"G Parrinello","year":"2011","unstructured":"Parrinello G, Paterna S, Di Pasquale P, Torres D, Mezzero M, Cardillo M, Fasullo S, La Rocca G, Licata G (2011) Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure. J Card Fail 17:331\u2013339","journal-title":"J Card Fail"},{"key":"6132_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","volume":"342","author":"S Paterna","year":"2011","unstructured":"Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, Terrazzino G, Maringhini G, Ganci F, Scalzo S, Sarullo FM, Cice G, Di Pasquale P (2011) Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci 342:27\u201337","journal-title":"Am J Med Sci"},{"key":"6132_CR32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1536\/ihj.16-313","volume":"58","author":"Y Wan","year":"2017","unstructured":"Wan Y, Li L, Niu H, Ma X, Yang J, Yuan C, Mu G, Zhang J (2017) Impact of compound hypertonic saline solution on decompensated heart failure. Int Heart J 58:601\u2013607","journal-title":"Int Heart J"},{"key":"6132_CR33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4330\/wjc.v9.i8.685","volume":"9","author":"G Lafreniere","year":"2017","unstructured":"Lafreniere G, Beliveau P, Begin JY, Simonyan D, Cote S, Gaudreault V, Israeli Z, Lavi S, Bagur R (2017) Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure. World J Cardiol 9:685\u2013692","journal-title":"World J Cardiol"},{"key":"6132_CR34","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00134-019-05772-1","volume":"45","author":"N Van Regenmortel","year":"2019","unstructured":"Van Regenmortel N, Hendrickx S, Roelant E, Baar I, Dams K, Van Vlimmeren K, Embrecht B, Wittock A, Hendriks JM, Lauwers P, Van Schil PE, Van Craenenbroeck AH, Verbrugghe W, Malbrain M, Van den Wyngaert T, Jorens PG (2019) 154 compared to 54\u00a0mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized controlled double-blind trial. Intensive Care Med 45:1422\u20131432","journal-title":"Intensive Care Med"},{"key":"6132_CR35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/bja\/aex118","volume":"118","author":"N Van Regenmortel","year":"2017","unstructured":"Van Regenmortel N, De Weerdt T, Van Craenenbroeck AH, Roelant E, Verbrugghe W, Dams K, Malbrain M, Van den Wyngaert T, Jorens PG (2017) Effect of isotonic versus hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis: a crossover study in fasting adult volunteers. Br J Anaesth 118:892\u2013900","journal-title":"Br J Anaesth"},{"key":"6132_CR36","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0140-6736(02)08711-1","volume":"359","author":"DN Lobo","year":"2002","unstructured":"Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP (2002) Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet 359:1812\u20131818","journal-title":"Lancet"},{"key":"6132_CR37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","volume":"12","author":"JC Schefold","year":"2016","unstructured":"Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S (2016) Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 12:610\u2013623","journal-title":"Nat Rev Nephrol"},{"key":"6132_CR38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/bja\/aer515","volume":"108","author":"TE Woodcock","year":"2012","unstructured":"Woodcock TE, Woodcock TM (2012) Revised starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108:384\u2013394","journal-title":"Br J Anaesth"},{"key":"6132_CR39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jped.2015.01.004","volume":"91","author":"MC Valadao","year":"2015","unstructured":"Valadao MC, Piva JP, Santana JC, Garcia PC (2015) Comparison of two maintenance electrolyte solutions in children in the postoperative appendectomy period: a randomized, controlled trial. J Pediatr 91:428\u2013434","journal-title":"J Pediatr"},{"key":"6132_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009457.pub2","author":"S McNab","year":"2014","unstructured":"McNab S, Ware RS, Neville KA, Choong K, Coulthard MG, Duke T, Davidson A, Dorofaeff T (2014) Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009457.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6132_CR41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapediatrics.2014.3809","volume":"169","author":"JN Friedman","year":"2015","unstructured":"Friedman JN, Beck CE, DeGroot J, Geary DF, Sklansky DJ, Freedman SB (2015) Comparison of isotonic and hypotonic intravenous maintenance fluids: a randomized clinical trial. JAMA Pediatr 169:445\u2013451","journal-title":"JAMA Pediatr"},{"key":"6132_CR42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/000313481207800936","volume":"78","author":"JC Duchesne","year":"2012","unstructured":"Duchesne JC, Simms E, Guidry C, Duke M, Beeson E, McSwain NE, Cotton B (2012) Damage control immunoregulation: is there a role for low-volume hypertonic saline resuscitation in patients managed with damage control surgery? Am Surg 78:962\u2013968","journal-title":"Am Surg"},{"key":"6132_CR43","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/00000542-200405000-00012","volume":"100","author":"JA Kolsen-Petersen","year":"2004","unstructured":"Kolsen-Petersen JA, Nielsen JO, Tonnesen EM (2004) Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology 100:1108\u20131118","journal-title":"Anesthesiology"},{"key":"6132_CR44","first-page":"600","volume":"116","author":"J Lambeck","year":"2019","unstructured":"Lambeck J, Hieber M, Dressing A, Niesen WD (2019) Central pontine myelinosis and osmotic demyelination syndrome. Deutsch Arztebl Int 116:600\u2013606","journal-title":"Deutsch Arztebl Int"},{"key":"6132_CR45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/ALN.0b013e31829416ba","volume":"119","author":"DA Story","year":"2013","unstructured":"Story DA, Lees L, Weinberg L, Teoh SY, Lee KJ, Velissaris S, Bellomo R, Wilson SJ (2013) Cognitive changes after saline or plasmalyte infusion in healthy volunteers: a multiple blinded, randomized, cross-over trial. Anesthesiology 119:569\u2013575","journal-title":"Anesthesiology"},{"key":"6132_CR46","first-page":"251","volume":"89","author":"VS Issa","year":"2007","unstructured":"Issa VS, Bacal F, Mangini S, Carneiro RM, Azevedo CH, Chizzola PR, Ferreira SM, Bocchi EA (2007) Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure. Arq Bras Cardiol 89:251\u2013255","journal-title":"Arq Bras Cardiol"},{"key":"6132_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/00365510410003138","volume":"65","author":"JA Kolsen-Petersen","year":"2005","unstructured":"Kolsen-Petersen JA, Nielsen JO, Tonnesen E (2005) Acid base and electrolyte changes after hypertonic saline (7.5%) infusion: a randomized controlled clinical trial. Scand J Clin Lab Invest 65:13\u201322","journal-title":"Scand J Clin Lab Invest"},{"key":"6132_CR48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF02471385","volume":"10","author":"S Kato","year":"1996","unstructured":"Kato S, Goto F (1996) Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. J Anesth 10:170\u2013175","journal-title":"J Anesth"},{"key":"6132_CR49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40635-018-0174-5","volume":"6","author":"CA Pfortmueller","year":"2018","unstructured":"Pfortmueller CA, Uehlinger D, von Haehling S, Schefold JC (2018) Serum chloride levels in critical illness-the hidden story. Intensive Care Med Exp 6:10","journal-title":"Intensive Care Med Exp"},{"key":"6132_CR50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1060028019891986","volume":"54","author":"J Sigmon","year":"2020","unstructured":"Sigmon J, May CC, Bryant A, Humanez J, Singh V (2020) Assessment of acute kidney injury in neurologically injured patients receiving hypertonic sodium chloride: does chloride load matter? Ann Pharmacother 54:541\u2013546","journal-title":"Ann Pharmacother"},{"key":"6132_CR51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13613-016-0193-x","volume":"6","author":"N Van Regenmortel","year":"2016","unstructured":"Van Regenmortel N, Verbrugghe W, Van den Wyngaert T, Jorens PG (2016) Impact of chloride and strong ion difference on ICU and hospital mortality in a mixed intensive care population. Ann Intensive Care 6:91","journal-title":"Ann Intensive Care"},{"key":"6132_CR52","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3346\/jkms.2016.31.8.1337","volume":"31","author":"MJ Han","year":"2016","unstructured":"Han MJ, Park KH, Shin J-h, Kim SH (2016) Influence of daily fluid balance prior to continuous renal replacement therapy on outcomes in critically Ill patients. J Korean Med Sci 31:1337\u20131344","journal-title":"J Korean Med Sci"},{"key":"6132_CR53","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/cc12484","volume":"17","author":"C Teixeira","year":"2013","unstructured":"Teixeira C, Garzotto F, Piccinni P, Brienza N, Iannuzzi M, Gramaticopolo S, Forfori F, Pelaia P, Rocco M, Ronco C, Anello CB, Bove T, Carlini M, Michetti V, Cruz DN, Investigators NEeCI (2013) Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 17:R14","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-06132-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-020-06132-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-06132-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T23:08:52Z","timestamp":1623193732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-020-06132-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["6132"],"URL":"https:\/\/doi.org\/10.1007\/s00134-020-06132-0","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"7 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CAP, MK, NVS, ASM, BH, LJ, SW, JW, PZ, FS, SMJ, and JCS report Grants from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dr\u00e4ger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Phagenesis Ltd, and Nycomed outside the submitted work. The money was paid into departmental funds; no personal financial gain applied. Lars Englberger has no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}